Nurix Therapeutics, Inc.
Industry: Life Sciences ・ $NRIX on Nasdaq
Insider Sale
+$86,097
-9.51%
Shares
Shares Volume: 3,546 Shares
Average Share Price: $24.28
INSIDER
van Houte Hans
Chief Financial Officer (Officer)
reported on Nov 1 2024
traded on Nov 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 33,724 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $121,937.08 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 30 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $96,229.4 |
| COMPANY PREVIOUS TRADES |